vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $19.2M, roughly 2.0× Apyx Medical Corp). On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 11.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 36.0%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
APYX vs CWBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $38.3M |
| Net Profit | $-1.3M | — |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 40.0% |
| Net Margin | -6.8% | — |
| Revenue YoY | 34.7% | 11.6% |
| Net Profit YoY | 71.9% | — |
| EPS (diluted) | — | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $38.3M | ||
| Q3 25 | $12.9M | $37.9M | ||
| Q2 25 | $11.4M | $35.7M | ||
| Q1 25 | $9.4M | $34.8M | ||
| Q4 24 | $14.2M | $34.3M | ||
| Q3 24 | $11.5M | $31.3M | ||
| Q2 24 | $12.1M | $30.5M | ||
| Q1 24 | $10.2M | $20.7M |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-2.0M | $10.9M | ||
| Q2 25 | $-3.8M | $7.8M | ||
| Q1 25 | $-4.2M | $8.3M | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | $3.4M | ||
| Q2 24 | $-6.6M | $-6.3M | ||
| Q1 24 | $-7.6M | $3.7M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 40.0% | ||
| Q3 25 | -6.5% | 39.8% | ||
| Q2 25 | -22.6% | 30.2% | ||
| Q1 25 | -32.4% | 32.7% | ||
| Q4 24 | -21.4% | 31.0% | ||
| Q3 24 | -31.6% | 13.3% | ||
| Q2 24 | -45.7% | -25.9% | ||
| Q1 24 | -64.6% | 23.2% |
| Q4 25 | -6.8% | — | ||
| Q3 25 | -15.4% | 28.7% | ||
| Q2 25 | -33.2% | 22.0% | ||
| Q1 25 | -44.0% | 23.8% | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | 10.8% | ||
| Q2 24 | -54.0% | -20.7% | ||
| Q1 24 | -74.0% | 17.8% |
| Q4 25 | — | $0.58 | ||
| Q3 25 | — | $0.57 | ||
| Q2 25 | — | $0.41 | ||
| Q1 25 | — | $0.44 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | — | $0.18 | ||
| Q2 24 | $-0.19 | $-0.33 | ||
| Q1 24 | $-0.22 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $119.0M |
| Total DebtLower is stronger | $37.5M | $69.5M |
| Stockholders' EquityBook value | $14.5M | $409.6M |
| Total Assets | $66.8M | $3.7B |
| Debt / EquityLower = less leverage | 2.58× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $119.0M | ||
| Q3 25 | $25.1M | $121.6M | ||
| Q2 25 | $29.3M | $134.4M | ||
| Q1 25 | $31.0M | $148.4M | ||
| Q4 24 | $31.7M | $120.4M | ||
| Q3 24 | $28.0M | $149.0M | ||
| Q2 24 | $32.7M | $109.7M | ||
| Q1 24 | $37.3M | $61.0M |
| Q4 25 | $37.5M | $69.5M | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | $69.9M | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $409.6M | ||
| Q3 25 | $5.8M | $397.6M | ||
| Q2 25 | $7.3M | $380.0M | ||
| Q1 25 | $10.5M | $372.2M | ||
| Q4 24 | $14.2M | $362.7M | ||
| Q3 24 | $11.0M | $363.5M | ||
| Q2 24 | $14.7M | $350.2M | ||
| Q1 24 | $20.3M | $211.7M |
| Q4 25 | $66.8M | $3.7B | ||
| Q3 25 | $57.4M | $3.6B | ||
| Q2 25 | $58.2M | $3.6B | ||
| Q1 25 | $60.2M | $3.6B | ||
| Q4 24 | $64.8M | $3.5B | ||
| Q3 24 | $60.7M | $3.5B | ||
| Q2 24 | $65.4M | $3.5B | ||
| Q1 24 | $70.7M | $2.4B |
| Q4 25 | 2.58× | 0.17× | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | 0.19× | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $46.1M |
| Free Cash FlowOCF − Capex | $-2.8M | $43.6M |
| FCF MarginFCF / Revenue | -14.6% | 113.9% |
| Capex IntensityCapex / Revenue | 1.4% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $46.1M | ||
| Q3 25 | $-3.5M | $13.2M | ||
| Q2 25 | $-1.2M | $11.5M | ||
| Q1 25 | $-702.0K | $11.1M | ||
| Q4 24 | $-2.9M | $22.2M | ||
| Q3 24 | $-4.4M | $7.8M | ||
| Q2 24 | $-4.3M | $5.2M | ||
| Q1 24 | $-6.3M | $4.0M |
| Q4 25 | $-2.8M | $43.6M | ||
| Q3 25 | $-4.1M | $12.8M | ||
| Q2 25 | $-1.5M | $10.6M | ||
| Q1 25 | $-757.0K | $10.8M | ||
| Q4 24 | $-3.2M | $17.2M | ||
| Q3 24 | $-4.6M | $5.2M | ||
| Q2 24 | $-4.6M | $4.8M | ||
| Q1 24 | $-6.4M | $3.6M |
| Q4 25 | -14.6% | 113.9% | ||
| Q3 25 | -31.5% | 33.7% | ||
| Q2 25 | -13.2% | 29.6% | ||
| Q1 25 | -8.0% | 30.9% | ||
| Q4 24 | -22.4% | 50.0% | ||
| Q3 24 | -40.0% | 16.7% | ||
| Q2 24 | -38.0% | 15.7% | ||
| Q1 24 | -62.2% | 17.3% |
| Q4 25 | 1.4% | 6.6% | ||
| Q3 25 | 4.0% | 1.1% | ||
| Q2 25 | 2.3% | 2.7% | ||
| Q1 25 | 0.6% | 0.9% | ||
| Q4 24 | 1.7% | 14.7% | ||
| Q3 24 | 1.3% | 8.1% | ||
| Q2 24 | 2.4% | 1.4% | ||
| Q1 24 | 0.3% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
